Premium Only Content
This video is only available to Rumble Premium subscribers. Subscribe to
enjoy exclusive content and ad-free viewing.

Gilead Shares Early Results Of Remdesivir Trial In COVID-19 Patients
5 years ago
346
Sci/Health
coronavirus
U.S.
covid-19
remdesivir
patients
study
gilead
gildead sciences
symptoms
standard care
Patients given remdesivir for five days had improved symptoms compared to those who were only given standard care.
Loading 1 comment...
-
2:45
Newsy
2 years agoSupreme Court weighs Google's liability in ISIS terror case
16.9K110 -
1:01
Newsy
5 years agoTrial Finds Remdesivir As Beneficial COVID-19 Drug, NIH Says
9752 -
0:24
KJRH
5 years agoOU Medicine Announces New Clinical Trial to Treat COVID-19 Patients
37 -
0:27
KTNV
5 years agoHeartburn drug could help COVID-19 patients
238 -
2:28
KMTV
5 years agoWoman shares experience with COVID-19
769 -
2:09
WMAR
5 years agoApp identifies symptoms, helps patients seek COVID-19 treatment
132 -
0:30
KTNV
5 years agoRobot dog helps COVID-19 patients communicate
5281 -
2:06
KSHB
5 years agoTesting cancer patients for COVID-19
250 -
3:23
WCPO
5 years agoPatients delaying care due to COVID-19
12 -
2:45
KTNV
5 years agoUMC using hydroxychloroquine for COVID-19 patients
1.54K2